References
- Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidem Biomar 2010;19:1893–1907.
- Crozier JA, Swaika A, Moreno-Aspitia A. Adjuvant chemotherapy in breast cancer: to use or not to use, the anthracyclines. World J Clin Oncol 2014;5:529–538.
- DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. Cancer J Clin 2014;64:252–271.
- Xu P, Meng Q, Sun H, et al. Shrapnel nanoparticles loading docetaxel inhibit metastasis and growth of breast cancer. Biomaterials 2015;64:10–20.
- Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005;121:335–348.
- Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 2010;7:653–664.
- Fan Y, Du W, He B, et al. The reduction of tumor interstitial fluid pressure by liposomal imatinib and its effect on combination therapy with liposomal doxorubicin. Biomaterials 2013;34:2277–2288.
- Netti PA, Berk DA, Swartz MA, et al. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 2000;60:2497–2503.
- Diop-Frimpong B, Chauhan VP, Krane S, et al. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc Natl Acad Sci USA 2011;108:2909–2914.
- Fang M, Yuan J, Peng C, Li Y. Collagen as a double-edged sword in tumor progression. Tumor Biol 2014;35:2871–2882.
- Chauhan VP, Martin JD, Liu H, et al. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat Commun 2013;4:2516. doi: 10.1038/ncomms3516.
- Zhang L, Wang Y, Yang Y, et al. High tumor penetration of paclitaxel loaded pH sensitive cleavable liposomes by depletion of tumor collagen I in breast cancer. Acs Appl Mater Inter 2015;7:9691–9701.
- Soltis EE, Jewell AL, Dwoskin LP, Cassis LA. Acute and chronic effects of losartan (DuP 753) on blood pressure and vascular reactivity in normotensive rats. Clin Exp Hypertens 1993;15:171–184.
- Fassot C, Lambert G, Gaudet-Lambert E, et al. Beneficial effect of renin-angiotensin system for maintaining blood pressure control following subarachnoid haemorrhage. Brain Res Bull 1999;50:127–132.
- Chen M, Zeng Z, Qu X, et al. Biocompatible anionic polyelectrolyte for improved liposome based gene transfection. Int J Pharmaceut 2015;490:173–179.
- Hama S, Itakura S, Nakai M, et al. Overcoming the polyethylene glycol dilemma via pathological environment-sensitive change of the surface property of nanoparticles for cellular entry. J Control Release 2015;206:67–74.
- Song H, Zhang J, Liu X, et al. Development of a bone targeted thermosensitive liposomal doxorubicin formulation based on a bisphosphonate modified non-ionic surfactant. Pharm Dev Technol 2015;21:680–687.
- Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 1989;49:4373–4384.
- Tian L, Bae YH. Cancer nanomedicines targeting tumor extracellular pH. Colloids Surf B Biointerf 2012;99:116–126.
- Zhang W, Song J, Zhang B, et al. Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells. Bioconjugate Chem 2011;22:1410–1415.
- Toriyabe N, Hayashi Y, Harashima H. The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine. Biomaterials 2013;34:1337–1343.
- Wu H, Zhu L, Torchilin VP. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. Biomaterials 2013;34:1213–1222.
- Zhang Q, Tang J, Fu L, et al. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. Biomaterials 2013;34:7980–7993.
- Shi K, Li J, Cao Z, et al. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma. J Control Release 2015;217:138–150.
- Shi K, Long Y, Xu C, et al. Liposomes combined an integrin αvβ3-specific vector with pH-responsible cell-penetrating property for highly effective antiglioma therapy through the blood–brain barrier. Acs Appl Mater Inter 2015;7:21442–21454.
- Clerc S, Barenholz Y. Loading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradients. Biochim Biophys Acta 1995;1240:257–265.
- Kheirolomoom A, Kruse DE, Qin S, et al. Enhanced in vivo bioluminescence imaging using liposomal luciferin delivery system. J Control Release 2010;141:128–136.
- Yang T, Choi M, Cui F, et al. Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. J Control Release 2007;120:169–177.
- Jung SH, Kim SK, Jung SH, et al. Increased stability in plasma and enhanced cellular uptake of thermally denatured albumin-coated liposomes. Colloids Surf B: Biointerf 2010;76:434–440.
- Vafaei SY, Dinarvand R, Esmaeili M, et al. Controlled-release drug delivery system based on fluocinolone acetonide–cyclodextrin inclusion complex incorporated in multivesicular liposomes. Pharm Dev Technol 2014;20:775–781.
- Jiang T, Zhang Z, Zhang Y, et al. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Biomaterials 2012;33:9246–9258.
- Guo Y, Wang L, Lv P, Zhang P. Transferrin-conjugated doxorubicin-loaded lipid-coated nanoparticles for the targeting and therapy of lung cancer. Oncol Lett 2015;9:1065–1072.
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
- Schroeder BR, Ghare MI, Bhattacharya C, et al. The disaccharide moiety of bleomycin facilitates uptake by cancer cells. J Am Chem Soc 2014;136:13641–13656.
- Pignatello R, Musumeci T, Graziano A, et al. A study on liposomal encapsulation of a lipophilic prodrug of LHRH. Pharm Dev Technol 2015;21:664–671.
- Mo R, Sun Q, Xue J, et al. Multistage pH-responsive liposomes for mitochondrial-targeted anticancer drug delivery. Adv Mater 2012;24:3659–3665.
- Jiang L, Li L, He X, et al. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response. Biomaterials 2015;52:126–139.
- Shegokar R, Singh KK, Müller RH. Production & stability of stavudine solid lipid nanoparticles—from lab to industrial scale. Int J Pharmaceut 2011;416:461–470.
- Liu Y, Ran R, Chen J, et al. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting. Biomaterials 2014;35:4835–4847.
- Wolman M, Klatzo I, Chui E, et al. Evaluation of the dye-protein tracers in pathophysiology of the blood-brain barrier. Acta Neuropathol 1981;54:55–61.
- Ogawara K, Un K, Minato K, et al. Determinants for in vivo anti-tumor effects of PEG liposomal doxorubicin: importance of vascular permeability within tumors. Int J Pharmaceut 2008;359:234–240.
- Mei L, Liu Y, Zhang Q, et al. Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin. J Control Release 2014;196:324–331.